Number of pages: 100 | Report Format: PDF | Published date: July 15, 2022
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
According to the deep-dive market assessment study by Growth Plus Reports, the global skin grafting market was valued at US$ 1.12 billion in 2022 and is expected to register a revenue CAGR of 6.8% to reach US$ 2.03 billion by 2031.
Skin Grafting Market Fundamentals
Skin grafting is done when healthy skin is transferred to another body part to replace lost or damaged skin. It is frequently used to treat severe burns, persistent wounds, traumatic injuries, and certain skin conditions. The knowledge of a qualified surgeon is necessary for difficult skin grafting surgery for skin grafting. Depending on the patient's unique requirements, the severity of the damage or ailment, and the intended results, the type of transplant and surgical procedure is selected. The success rates and cosmetic outcomes of skin grafting surgeries continue to be enhanced by developments in medical technology and practices.
Skin grafting can be used to treat non-healing wounds such as diabetic foot ulcers, venous leg ulcers, and pressure sores. It helps to cover burn wounds, increase healing, minimize infection risk, and enhance function and aesthetics. The transplant offers healthy skin to help close wounds and speed up recovery. Additionally, skin grafting can be used to restore skin that has been severely damaged by trauma, such as deep lacerations or avulsion wounds. Skin grafts can be used to restore pigmentation or enhance the appearance of some skin diseases, such as widespread vitiligo or big birthmarks.
Skin Grafting Market Dynamics
Skin grafts are ideally favored post-surgery for skin cancers. To maintain the closure of the surgical bed established during radiation, skin grafts are typically referred to for local postoperative radiotherapy (PORT). According to Cancer Research U.K., 42 new instances of melanoma skin cancer are reported in the U.K. daily, totaling 15,400 new cases each year. Between 2014 and 2035, the UK's melanoma skin cancer incidence rates are expected to increase by 7%, reaching 32 incidences per 100,000 persons. Similarly, 19.3 million new instances of cancer, excluding 18.1 million cases of nonmelanoma skin cancer, were reported in 2020, according to data just released by the International Agency for Research on Cancer. Consequently, a rise in the frequency of skin cancer is likely to cause skin grafting in the coming future.
One of the most widespread medical disorders in the world is diabetes. 537 million persons (20-79 years old) are estimated to have diabetes, according to the IDF Diabetes Atlas Ninth Edition 2021. By 2030, there will be 643 million diabetics globally, and by 2045, there will be 783 million. In nations with low and intermediate incomes, 3 out of 4 individuals with diabetes reside. Adults with diabetes comprise almost one in two people (240 million). Diabetes resulted in 6.7 million deaths and at least 966 billion dollars in medical costs, or 9% of all adult spending. Type 1 diabetes affects more than 1.2 million children and teenagers (0-19 years). Diabetes patients experience slower wound healing, which raises the risk of skin infections if it is not healed within a particular time. Approximately 25% of diabetes people will likely get foot ulcers at some point in their lives, which frequently require advanced diabetic wound care. Due to the reduced risk of skin infections, there is a rise in the demand for skin transplants to cure or cover diabetic foot ulcers. Thus, it is anticipated that the increased prevalence of diabetes and skin cancer will propel the skin graft market in the near future.
However, the adverse effects of skin grafting, on the other hand, are a significant barrier to expanding the skin transplant market. The intricacy and high expense of the skin grafting treatment method are additional factors limiting the expansion of the skin graft sector.
Skin Grafting Market Ecosystem
The global skin grafting market is analyzed from the following perspectives by graft type, product, application, end user, and region.
Skin Grafting Market by Graft Type
Based on the graft type, the global skin grafting market is segmented into autograft, allograft, xenograft, isograft, and prosthetic graft.
The autograft segment held the largest market share in the global skin grafting market in 2022, and the market for that same segment is predicted to grow at a revenue CAGR of 7.2% during the forecast period from 2023 to 2031. The widespread use of autologous grafts for treating open burns and wounds might be ascribed to the market expansion for the autograft segment.
Skin Grafting Market by Product
Based on the product, the global skin grafting market is segmented into graft mesher, dermatome, wound debridement devices, and others.
The graft mesher segment will likely show significant growth during the forecast period. A graft mesher is a medical tool used during the skin-grafting procedure. It is intended to particularly produce mesh patterns in skin transplants, which has several benefits. Better wound coverage, higher graft adhesion, increased vascularization, and quicker wound healing are all made possible using graft meshers in skin grafting. It is a crucial tool in the surgical treatment of severe burns, persistent wounds, and other disorders requiring skin grafts.
Skin Grafting Market by Application
Based on the application, the global skin grafting market is segmented into burns, surgical wounds, traumatic wounds, chronic wounds, and others.
The burn segment will likely grow significantly during the forecasted period. The expansion of the burns market is primarily driven by the increased frequency of these injuries, high demand for skin grafts, increased patient knowledge of available treatments, and technical improvements. For instance, according to the National Library of Medicine, over 160,000 skin grafts are carried out annually in almost one out of every three burn hospitalizations, according to the Healthcare Cost and Utilization Project. If enough donor tissue and a healthy recipient bed are available, their utilization is common since they are generally simple and quick.
A major element influencing the market is patients' growing awareness of the range of available treatment and care alternatives. In 2020, when SARS-Cov-2 (COVID-19) was a worldwide epidemic, most healthcare systems concentrated on disease prevention. Personal protective equipment (PPE), social exclusion, testing and quarantining of infected cases, and streamlining healthcare systems to prioritize intensive care resources are the major methods used to stop the spread of illness.
Skin Grafting Market by End User
Based on the end user, the global skin grafting market is segmented into hospitals & clinics, research institutes, and ambulatory surgical centers.
The hospitals & clinics segment will likely dominate the market during the forecast period. The use of skin grafting techniques depends greatly on hospitals and clinics. To undertake skin grafting procedures and provide patients with full treatment, they provide the required facilities, expert medical personnel, and resources. For patients getting skin grafts, hospitals and clinics offer preoperative treatment and preparation. This involves ensuring the patient is in the best possible health for surgery, informing the patient about the treatment, reviewing the anticipated results and any risks, getting informed permission, and more. Hospitals and clinics may also provide rehabilitation services, such as physical and occupational therapy when skin grafting is carried out for severe burns or traumatic injuries. These services help patients regain function and get used to their new skin.
Skin Grafting Market by Region
Based on the region, the global skin grafting market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
The growing demand for skin grafts and replacements and the rising number of burn injuries are the main drivers propelling the market expansion in North America. In addition, the existence of major market players in this area who are focused on strategic initiatives, including introducing new products and mergers and acquisitions, is anticipated to open up profitable growth prospects. In the United States during the COVID-19 pandemic 2020, the University of Iowa started offering burn services, such as electronic communication platforms for communication and telemedicine services, to communicate with both clinics and hospitals, according to a research article by Juan P. Barret et al., published in Burns Journal. The burn facilities in the US maintained stringent safeguards with remarkable discipline during the COVID-19 outbreak. COVID-positive burn patients were effectively treated as a member of the COVID-positive cohort.
Over the projection period, the Asia Pacific market is expected to develop the fastest revenue CAGR of 7.2% during the forecast period. The rate of burn injuries requiring emergency medical attention is around 20 times greater in the Western Pacific Region than in the Americas; according to the World Health Organization, more than 100,000 people in India suffer mild to severe burns every year. Every year, over 173 000 Bangladeshi children suffer mild to severe burns. 17% of burnt children in Bangladesh, Colombia, Egypt, and Pakistan have a temporary handicap, while 18% have a permanent one. With 5% of disability, burns are the second most prevalent injury in rural Nepal.
Additionally, a significant factor driving the market in this region is the rise in burn injuries and chronic wounds. For instance, according to estimates of 1.51 to 2.21 chronic wounds per 1000 people worldwide, the frequency is predicted to increase as the world's population ages. Chronic wounds can have a variety of etiologies, and they have frequently been divided into the following groups: pressure injuries (PIs), diabetic foot ulcers (DFUs), wounds associated with peripheral artery disease, venous leg ulcers, and unusual hard-to-heal wounds. Throughout the projected period, the market expansion is anticipated to be fueled by the rising R&D efforts of significant industry players to launch novel products.
Skin Grafting Market Competitive Landscape
Some of the prominent market players in the global skin grafting market include,
Skin Grafting Market Strategic Development
Skin grafting is when healthy skin is transferred to another body part to replace lost or damaged skin. It is frequently used to treat severe burns, persistent wounds, traumatic injuries, and certain skin conditions.
North America region is dominating the global skin grafting market.
The estimated market size of the skin grafting market in 2031 will be US$ 2.03 billion.
The revenue CAGR of the skin grafting market during the forecast period will be 6.8%.
Some of the major market players in the global skin grafting market include Smith & Nephew Plc, MiMedx, and Tissue Regenix.
*Insights on financial performance are subject to the availability of information in the public domain